A Comparison Of IV Ondansetron Vs IV Ondansetron And IV Dexamethasone In Preventing PONV In Patients Undergoing Laparoscopic Cholecystectomy.
IOSR Journal of Dental and Medical Sciences · 2026-07 · 25 (7) · 14-15
DOI: 10.9790/0853-2507031415 ↗Kurz gefasst
Fachartikel in der Zeitschrift IOSR Journal of Dental and Medical Sciences, 2026-07. Verfasst von Dr. Anvitha Anand und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Postoperative nausea and vomiting (PONV) are common complications after anaesthesia, particularly in laparoscopic surgeries like cholecystectomy due to the effects of anaesthesia itself, organ manipulation and surgical positioning. PONV causes delayed recovery, longer hospital-stay, and serious issues such as electrolyte imbalance, aspiration, and wound disruption. Prophylactic treatment with ondansetron and dexamethasone improves outcomes and enhances patient satisfaction. However, there is no standalone guideline/regimen that dictates which drugs are to be used for preventing PONV and this study may aid better clinical judgement for the same.
Aim
To compare ondansetron as a stand-alone drug vs a combination ondansetron and dexamethasone in preventing PONV in patients undergoing Laparoscopic cholecystectomy.
Methods
This study included patients undergoing elective laparoscopic cholecystectomy under general anaesthesia. After a written informed consent each patient was allotted into one of two groups. One group received only injection Ondansetron 4mg IV and the other group received both injections Ondansetron 4mg IV and Dexamethasone 8mg IV after induction of general anaesthesia. After patient extubation and shifting out of the OR, nausea and vomiting were assessed based on VAS Score of 0-10 at 0, 2, 3, 6, 12 and 24 hours.
Results
Of the two demographically similarly groups, the combination group showed a statistically significant reduction in both the Maximum VAS Score (mean 0.30±0.47 vs. 1.35±2.03; p=0.030) and the Total PONV Burden (p=0.033). This benefit was further confirmed by a Median Maximum VAS Score of 0.0 in the combination group and the achievement of a 0.0% incidence of vomiting vs a 15% incidence in the monotherapy group.
Conclusion
The prophylactic use of intravenous Ondansetron and Dexamethasone combination therapy is more effective than Ondansetron monotherapy for preventing and reducing the severity of PONV following laparoscopic cholecystectomy.
Zitieren
APA
Anand, D. A., & C, D. M. A. (2026). A Comparison Of IV Ondansetron Vs IV Ondansetron And IV Dexamethasone In Preventing PONV In Patients Undergoing Laparoscopic Cholecystectomy. IOSR Journal of Dental and Medical Sciences, 25(7), 14-15. https://doi.org/10.9790/0853-2507031415
Vancouver
Anand DA, C DMA. A Comparison Of IV Ondansetron Vs IV Ondansetron And IV Dexamethasone In Preventing PONV In Patients Undergoing Laparoscopic Cholecystectomy. IOSR Journal of Dental and Medical Sciences. 2026;25(7):14-15. doi:10.9790/0853-2507031415
BibTeX
@article{Anand2026,
author = {Anand, Dr. Anvitha and C, Dr. Manjunath A},
title = {A Comparison Of IV Ondansetron Vs IV Ondansetron And IV Dexamethasone In Preventing PONV In Patients Undergoing Laparoscopic Cholecystectomy},
journal = {IOSR Journal of Dental and Medical Sciences},
year = {2026},
volume = {25},
number = {7},
pages = {14--15},
doi = {10.9790/0853-2507031415}
}
EUVIMED